Akouos Receives Orphan Drug and Rare Pediatric Disease Designations for AK-OTOF for the Treatment of Otoferlin Gene-Mediated Hearing Loss
April 13, 2021 08:30 ET
|
Akouos, Inc.
BOSTON, April 13, 2021 (GLOBE NEWSWIRE) -- Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling...
Medolife Rx Submits Final Data Set to FDA for IND Filing on Lead Drug Candidate
April 13, 2021 08:30 ET
|
Quanta, Inc.
BURBANK, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
BOQI International Medical Inc. Enters into SPA to Acquire Three Hospitals
April 13, 2021 08:30 ET
|
BOQI International Medical, Inc.
NEW YORK, April 13, 2021 (GLOBE NEWSWIRE) -- BOQI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a leading healthcare products and services provider in China, today announced...
AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for Grade 1 Immune Checkpoint Inhibitor-Associated Colitis
April 13, 2021 08:30 ET
|
AzurRx BioPharma, Inc.
DELRAY BEACH, Fla., April 13, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development...
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) Annual Meeting
April 13, 2021 08:30 ET
|
GW Pharmaceuticals plc
EPIDOLEX encore presentations highlight long-term safety and efficacy data in patients with tuberous sclerosis complex (TSC) and other treatment-resistant epilepsies Nabiximols data show efficacy and...
CV Sciences and Alkemist Labs Form Partnership to Support the National Institute of Standards and Technology’s Cannabis Quality Assurance Program
April 13, 2021 08:30 ET
|
CV Sciences, Inc.
SAN DIEGO, April 13, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp derived cannabidiol (CBD) products,...
Voltron Therapeutics, Inc. Announces COVID-19 and Pandemic Preparedness Presentation to Congressional Offices and Agencies, Including HHS, NIH, FDA, and DoD
April 13, 2021 08:00 ET
|
Voltron Therapeutics, Inc.
NEW YORK, April 13, 2021 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. today announced that the Company presented to Congressional Offices and Agencies, including HHS, NIH, FDA and the DoD on...
Canyon Bakehouse® Unveils New Packaging Design
April 13, 2021 08:00 ET
|
Canyon Bakehouse
Johnstown, CO, April 13, 2021 (GLOBE NEWSWIRE) -- Canyon Bakehouse®, the No. 1 gluten-free bread brand in the U.S., is unveiling new packaging for their entire line of gluten-free breads, bagels,...
ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Infection in Sexual Assault Patients at the 2021 Academy of Managed Care Pharmacy Virtual Annual Meeting
April 13, 2021 08:00 ET
|
ADMA Biologics, Inc.
Poster Presentation Highlights the Unmet Patient Need and Medical Cost Burden Associated with Hepatitis B Infection Healthcare Costs Associated with HBV and HIV are Approximately at Parity; HBV...
Extendicare Announces Timing of 2021 First Quarter Results and Conference Call
April 13, 2021 08:00 ET
|
Extendicare Inc
MARKHAM, Ontario, April 13, 2021 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the first quarter...